Palo Alto Investors »

Nuvation Bio shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Nuvation Bio (NUVB) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Nuvation Bio

Tip: Access up to 7 years of quarterly data

All positions including Nuvation Bio held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvation Bio by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.8M 773k 3.64

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
Amicus Therapeutics (FOLD)
BioMarin Pharmaceutical (BMRN)
Biogen Idec (BIIB)
United Therapeutics Corporation (UTHR)
Staar Surgical Com Par $0.01 (STAA)
ACADIA Pharmaceuticals (ACAD)
Prothena Corp SHS (PRTA)
Iovance Biotherapeutics (IOVA)
Alnylam Pharmaceuticals (ALNY)
Sarepta Therapeutics (SRPT)
Revance Therapeutics (RVNC)
Sage Therapeutics (SAGE)
Anaptysbio Inc Common (ANAB)
eHealth (EHTH)

View all positions for Palo Alto Investors

Top funds holding Nuvation Bio

FMR
EcoR1 Capital
Omega Fund Management
BlackRock
Vanguard Group
Abrams Capital Management
Tang Capital Management
Geode Capital Management
Redmile Group
Aisling Capital Management
Citadel Advisors
Barclays
Octagon Capital Advisors
T. Rowe Price Associates
AWM Investment Company

View all funds holding Nuvation Bio